BioMedNewsBreaks

WednesdaySep 22, 2021 12:30 pm

BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Present at Benzinga Healthcare Small Cap Conference

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild to moderate obstructive sleep apnea (“OSA”), today announced that its chairman and CEO Kirk Huntsman and CFO Brad Amman will be presenting at the online Benzinga Healthcare Small Cap Conference at 2:20 pm ET on Wednesday, Sept. 29, 2021. The event is scheduled to take place from Sept. 29-30, 2021. Investors interested in joining the Vivos presentation should visit https://ibn.fm/JFY3h to register for a free spectator pass. A replay of the presentation will be available for view…

Continue Reading

FridaySep 17, 2021 3:08 pm

BioMedNewsBreaks – RYAH Group Inc. (CSE: RYAH) Leveraging IoT Devices, AI Analytics to Provide Innovative Plant-Based Treatments

RYAH Group (CSE: RYAH), a connected device and big data and technology company, recently released a report outlining cannabis treatment options to address symptoms and conditions associated with HIV and AIDS. The report is based on information compiled by the RYAH Data Ecosystem, which enabled patients to submit data outlining symptoms they addressed with the use of cannabis, in addition to detailing specific cannabis strains used to treat those conditions. A recent article reads, “The ground-breaking report is part of RYAH’s data-driven mission to provide innovative plant-based medical treatments that leverage the use of IoT (Internet of Things) dose-measuring devices…

Continue Reading

FridaySep 17, 2021 12:33 pm

BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Names World-Renowned Thought Leader as Advisory Board Member

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announced that Dr. Osama Hamdy, MD, PhD, has joined its advisory board. Hamdy will act as a consultant and will provide invaluable input regarding key opinion leader studies in both the diabetes and metabolic health fields using Nemaura’s glucose monitoring technology. An acclaimed endocrinologist, Hamdy is medical director of the Obesity Clinic Program at the Joslin Diabetes Center; he is also an associate professor of medicine at Harvard Medical School. He has built a stellar reputation as…

Continue Reading

FridaySep 17, 2021 12:09 pm

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM), BayMedica Slated to Participate in Tribe Public Webinar

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has announced that its CEO Eric A. Adams will be a featured presenter at Tribe Public’s upcoming complimentary ZOOM presentation titled “Accelerating The Commercialization of Rare Cannabinoids.” The webinar is scheduled to begin on Sept. 21, 2021, at 11.30 a.m. ET. In addition to Adams, BayMedica Inc. cofounder Shane Johnson will also present during the event. Adams and Johnson’s presentation will be hosted by Tribe Public managing member John F. Heerdink Jr., who will field live questions and pass those on to the presenters. In…

Continue Reading

FridaySep 17, 2021 9:56 am

BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Exec to Participate in Upcoming in Mental Health Virtual Conference

Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, has announced that president and CEO Kelsey Ramsden will be participating in the Advances in Mental Health Virtual Conference. The one-day conference, presented by Maxim Group LLC and hosted by M-Vest, is scheduled for Sept. 22, 2021. Ramsden will be a panel member in two separate sessions held during the virtual event. The panels, which are part of the “Disruptors in the Mental Health Space” series, are titled “The Second Generation – Beyond Psilocybin and MDMA”and “Delivery, Manufacturing and Technology” and will…

Continue Reading

ThursdaySep 16, 2021 9:35 am

BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Announces Partnership Digital Therapeutics Alliance

Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, is joining the Digital Therapeutics Alliance. A nonprofit association of industry leaders, the alliance is dedicated to driving awareness and adoption of digital therapies. MINDCURE announced that, as part of the alliance, the company is committed to providing value and reimbursement, policy and regulation, and awareness to educate the broader health-care industry about the benefits of including new technologies in current treatment regimes. Collaboration with the alliance is a strategic move as MINDCURE works to position iSTRYM, its proprietary software application, as…

Continue Reading

TuesdaySep 14, 2021 2:55 pm

BioMedNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Leveraging Partnerships to Save Patients’ Lives, Broaden Product Pipeline

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, recently announced a cooperation agreement with Roche Pharmaceuticals China, a subsidiary of Roche Holdings AG, to explore novel medical solutions. Under the agreement, “both parties plan to utilize AnPac Bio’s Cancer Differentiation Analysis (‘CDA’) cancer detection technology and Roche’s FoundationOne CDx to create a solution that customers with a high cancer risk level as assessed by CDA and later diagnosed with cancer can receive a personalized CDx precision medical test for therapy selection. The parties aim to help benefit the general population while lowering costs…

Continue Reading

TuesdaySep 14, 2021 2:36 pm

BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) Is Frontrunner in Support of Psychedelic-Assisted Therapy

Mind Cure Health (CSE: MCUR) (OTCQB: MCURF), a leader in advanced proprietary technology and research for psychedelics, is devoted to building access to safe, science- and evidence-backed psychedelic-assisted therapies globally. “The company has filed a provisional patent application for its pharmaceutical-grade synthetic ibogaine to be used in clinical research and anticipates developing that in conjunction with its software-as-a-service (‘SaaS’) platform iSTRYM,” reads a recent article. iSTRYM is designed to help physicians and patients manage psychiatric medications using smart “digital therapeutics” technology. On August 10, MCURF announced an agreement with Dr. Ken Weingardt to provide consulting services as a senior clinical…

Continue Reading

MondaySep 13, 2021 3:30 pm

BioMedNewsBreaks – Brain Scientific Inc. (BRSF) Poised to Offer Solution to Rising Challenge Facing Global Health Systems

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company, offers next-generation technological solutions for the neurology market. The company’s two FDA-cleared devices, NeuroCap(TM) and NeuroEEG(TM), allow quick and reliable EEG testing in minutes and by any health care worker, not only specialized neurological technicians, bringing brain diagnostics to settings in which neurological testing was previously impossible or difficult. “As we learn more about COVID-19, it is becoming increasingly clear that neurological care in the post-COVID world will be crucial,” reads a recent article. This revelation comes amid findings by scientists who are starting to collect more and more…

Continue Reading

MondaySep 13, 2021 11:05 am

BioMedNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Announces Engagement of Oak Hill Financial for Investor Relations, Advisory Services

Avricore Health (TSX.V: AVCR)(OTCQB: AVCRF) today announced that it has appointed Oak Hill Financial Services Inc. to provide the company with investor relations and advisory services. Toronto-based Oak Hill is a financial services provider that assists companies in enhancing their corporate profile. Under the agreement, Avricore will pay Oak Hill a fee of $12,000 per month for an initial three months. Oak Hill will provide services such as drafting marketing materials and reaching out to its Canadian investor network to expand Avricore’s visibility in the financial community. “We are really excited by Oak Hill’s track record of success in our sector,…

Continue Reading